WATERTOWN, Mass.– Konovo, a healthcare intelligence company focused on transforming life science market research through AI-powered data integration, has appointed Tim Albury as its new Chief Financial Officer.
Albury brings more than 35 years of experience in financial leadership within the healthcare and life sciences sectors. His appointment marks a strategic move for Konovo as it scales its AI-native platform designed to unify fragmented data and deliver actionable insights to healthcare and life science organizations.
“Tim Albury has proven that savvy financial operations are an engine of innovation that can propel the success of technology companies,” said Tal Rosenberg, CEO of Konovo. “We are eager to apply his guidance as we grow our platform and tackle persistent challenges in the market research industry.”
Before joining Konovo, Albury served as CFO of AQuity Solutions, where he played a key role in guiding the company from its early stages to a successful acquisition by IKS Health. His extensive resume also includes leadership roles at ConcertAI, CALYX, Liquidia Technologies, and Osmotica Pharmaceuticals, among others.
A licensed CPA, Albury has deep experience in private equity, mergers and acquisitions, and financial optimization. Known for a collaborative approach, he emphasizes cross-functional partnerships to drive profitability and long-term enterprise value. He holds a master’s degree in professional accountancy from the University of Miami and a bachelor’s degree in accounting from Liberty University.
As Konovo continues to expand its AI-first healthcare intelligence platform, Albury’s appointment is expected to strengthen the company’s financial strategy and operational discipline, supporting its mission to accelerate insight generation in life sciences.
